Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SGS Life Science Services, the leading pharmaceutical analytical and bioanalytical contract solutions provider, today announced that is to expand its Shanghai, China, cGMP chemistry and microbiology laboratories to 2000 square meter by Q2 2015 and ...
read more
Tuesday, February 27, 2018
Sherpa Clinical Packaging announced new Active Pharmaceutical Ingredient (API) sampling and storage services.
read more
Friday, February 21, 2020
Sihuan announced Xuanzhu Biopharmaceutical acquired all interests and intellectual property rights of plazomicin.
read more
Sirio Pharma announced the appointment of Mark Dewis as General Manager of the Sirio Americas Business Unit. Dr. Dewis brings more than 30 years of experience in the food, beverage, and nutritional supplement industries.
read more
Wednesday, January 08, 2020
Sirnaomics and Innovent Biologics announced they have entered a strategic collaboration to conduct clinical studies, using STP705 and Tyvyt.
read more
SK Capital has signed a definitive agreement to acquire Perrigo API business.
read more
Wednesday, November 22, 2017
SK Capital completed its previously announced acquisition of Perrigo Company API business.
read more
Tuesday, January 05, 2021
Slayback Pharma has received final approval for its ANDA for Merzee 1 mg/20 mcg from the FDA with a Competitive Generic Therapy Designation.
read more
Monday, December 30, 2019
Sosei Group has been notified by its strategic alliance partner Pfizer that it has nominated a third clinical candidate from the multi-target drug discovery collaboration between the two companies.
read more
Friday, December 22, 2017
SSCI has increased capacity in response to industry demand for the company’s cGMP particle characterization services by implementing Malvern’s next-generation laser diffraction instrument Mastersizer 3000.
read more
Friday, February 22, 2019
Assessing and mitigating risks is at the heart of everything we do across our vast portfolio.
read more
Sterling Pharma Solutions is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to midscale commercial API manufacturing capabilities.
read more
GHO Capital has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture APIs.
read more
Sterling Pharma Solutions has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
read more
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more